Association Between Body Mass Index and Disease Severity in Chinese Spinocerebellar Ataxia Type 3 Patients

被引:0
作者
Jin-Shan Yang
Ping-Ping Chen
Min-Ting Lin
Mei-Zhen Qian
Hui-Xia Lin
Xiao-Ping Chen
Xian-Jin Shang
Dan-Ni Wang
Yu-Chao Chen
Bin Jiang
Yi-Jun Chen
Ning Wang
Wan-Jin Chen
Shi-Rui Gan
机构
[1] First Affiliated Hospital of Fujian Medical University,Department of Neurology and Institute of Neurology
[2] Fujian Key Laboratory of Molecular Neurology,Interdisciplinary Institute of Neuroscience and Technology
[3] Zhejiang University,School of Mathematics and Computer Science & FJKLMAA
[4] Fujian Normal University,Department of Neurology
[5] Yijishan Hospital of Wannan Medical College,Department of Neurology
[6] The First Affiliated Hospital of Xiamen University,undefined
来源
The Cerebellum | 2018年 / 17卷
关键词
Spinocerebellar ataxia type 3; Machado-Joseph disease; Body mass index; Age at onset;
D O I
暂无
中图分类号
学科分类号
摘要
Spinocerebellar ataxia type 3 (SCA3), the most common subtype of SCA worldwide, is caused by mutation of CAG repeats expansion in ATXN3. Body mass index (BMI) is an important modulatory factor in the progression of neurodegenerative disorders such as Huntington disease and amyotrophic lateral sclerosis. However, its relevance in SCA3 is not well understood. In this study, BMI was investigated in 134 molecularly confirmed SCA3 patients and 136 healthy controls from China. The multivariable linear regression models were performed to establish the putative risk factors for BMI, and whether BMI could affect the severity of ataxia. We found that BMI was significantly lower in the case group than that in the control group. The age at onset (positive correlation) and severity of ataxia (negative correlation) were the risk factors affecting BMI. Conversely, BMI along with the disease duration, the age at onset, and the numbers of CAG repeats could also have influence on the severity of ataxia. In conclusion, SCA3 patients had lower BMI than matched controls and BMI is a predictor of disease progression in SCA3. Nutritional intervention to promote weight gain could be a promising strategy to impede SCA3 progression.
引用
收藏
页码:494 / 498
页数:4
相关论文
共 149 条
  • [1] Kawaguchi Y(1994)Cag expansions in a novel gene for machado-joseph disease at chromosome 14q32.1 Nat Genet 8 221-228
  • [2] Okamoto T(2010)High frequency of machado-joseph disease identified in southeastern chinese kindreds with spinocerebellar ataxia BMC Med Genet 11 47-894
  • [3] Taniwaki M(2010)Autosomal dominant cerebellar ataxias: polyglutamine expansions and beyond Lancet Neurol 9 885-804
  • [4] Aizawa M(1991)Factors associated with slow progression in Huntington’s disease Arch Neurol 48 800-2072
  • [5] Inoue M(2014)Hypercaloric enteral nutrition in patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled phase 2 trial Lancet 383 2065-3374
  • [6] Katayama S(2017)Comparison of spinocerebellar ataxia type 3 mouse models identifies early gain-of-function, cell-autonomous transcriptional changes in oligodendrocytes Hum Mol Genet 26 3362-697
  • [7] Kawakami H(2017)Body mass index decline is related to spinocerebellar ataxia disease progression Mov Disord Clin Pract 4 689-774
  • [8] Nakamura S(2012)Body mass index is inversely correlated with the expanded cag repeat length in sca3/mjd patients Cerebellum 11 771-211
  • [9] Nishimura M(2015)Population genetics and new insight into range of cag repeats of spinocerebellar ataxia type 3 in the han chinese population PLoS One 10 205-4292
  • [10] Akiguchi I(1997)International cooperative ataxia rating scale for pharmacological assessment of the cerebellar syndrome J Neurol Sci 145 4285-1540